Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
The classic Z-Pack taper isn't arbitrary. It reflects decades of pharmacokinetic research into how azithromycin behaves in the body.
Albendazole is the antiparasitic backbone for two serious tapeworm larval infections of humans, neurocysticercosis and hydatid disease, each requiring individualized, physician-guided care.
Ivermectin is manufactured for both people and animals, but under different rules, doses, and quality standards. Here is what actually separates them.
Why medicines are taken once, twice, or three times a day is not arbitrary. It follows directly from how quickly the body clears each drug.
Livestock and heartworm parasites are losing sensitivity to ivermectin. Here's what the veterinary evidence actually shows—and what it does and doesn't mean for humans.
A two-century journey from Andean tree bark to a modern immune-modulating drug, and what the clinical evidence actually shows about its uses today.
Azithromycin blocks bacteria from building proteins by jamming a tunnel deep inside their ribosomes. Here is the real molecular story, and what remains uncertain.
Parasitic and related infections affect over a billion of the world's poorest people yet attract a fraction of global health research funding.
Hydroxychloroquine can slowly damage the retina in long-term users. Here is what the ophthalmology guidelines actually require, and why the schedule matters.